Article Details

Adalimumab Biosimilar Pipeline Insight to Register Incremental Dollar Opportunity During COVID ...

Retrieved on: 2021-04-26 09:56:15

Tags for this article:

Click the tags to see associated articles and topics

Adalimumab Biosimilar Pipeline Insight to Register Incremental Dollar Opportunity During COVID .... View article details on hiswai:

Excerpt

MYL-1401A is a recombinant human IgG1 monoclonal antibody and is being evaluated as an injectable therapy for the treatment of rheumatoid arthritis ...

Article found on: ksusentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo